Document is current
Any future updates will be listed below
-
Authors
Xu, Yuanjun
Wu, Fan
Wu, Yilin
Zhuo, Enqing
Zeng, Jie
Cao, Donglin
-
Funding
Funding for this research was provided by:
Guangdong Second Provincial General Hospital Youth Fund (YQ2019-006, YQ2019-006, YQ2019-006, YQ2019-006, YQ2019-006, YQ2019-006)
Guangzhou Science and Technology Program Project (2023A03J0284, 2023A03J0284, 2023A03J0284, 2023A03J0284, 2023A03J0284, 2023A03J0284)
Guangdong Provincial Key R&D Programme (2022B1111020003, 2022B1111020003, 2022B1111020003, 2022B1111020003, 2022B1111020003, 2022B1111020003)
GuangDong Basic and Applied Basic Research Foundation (2021A1515220067;2021A1515110712, 2021A1515220067;2021A1515110712, 2021A1515220067;2021A1515110712, 2021A1515220067;2021A1515110712, 2021A1515220067;2021A1515110712, 2021A1515220067;2021A1515110712)
The Technology Research Program of Guangzhou City (202201020560;2023A03J0283, 202201020560;2023A03J0283, 202201020560;2023A03J0283, 202201020560;2023A03J0283, 202201020560;2023A03J0283, 202201020560;2023A03J0283)
- License Information
-
More Information
Article History
Received: 29 November 2024
Accepted: 21 August 2025
First Online: 25 September 2025
Declarations
:
: The authors declare no competing interests.
: The work described has not been published previously.
: Five pairs of CRC tumor tissues and adjacent tissues were purchased from Shanghai Outdo Biotech Company (Shanghai, China). Ethical approval was obtained from ethics committee of Shanghai Outdo Biotech Co., Ltd.
